Lixte Biotechnology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -774 | -706 | -1,574 | -984 |
EBIT | -1,413 | -609 | -983 | |
Net Income | -775 | -709 | -618 | -986 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -487 | -568 | -598 | -957 |
Cash | 887 | 1,384 | 1,038 | 1,637 |
Basic Shares | 2,720 | 2,471 | 2,249 | 2,249 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -3,573 | 3 | -1 | -7 |
EBIT | -3,602 | -5,086 | -6,312 | -6,728 |
Net Income | -3,586 | -5,087 | -6,312 | -6,728 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,164 | -4,293 | -4,611 | -4,142 |
Cash | 1,038 | 4,203 | 5,353 | 4,823 |
Basic Shares | 2,249 | 1,915 | 158 | 1,347 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.29 |
2025-03-31 | -$0.28 |
2024-12-31 | -$0.27 |
2024-09-30 | -$0.43 |
